CD19 and graft versus host disease: Expression of an anti-CD19-CAR in lymphoid progenitors was shown to suppress T cell development with the generation of cells with NK cell-like characteristics that had strong cytotoxic activity against CD19+ leukemia cells across MHC barriers and without causing GVHD.